Related Experiment Video
Updated: Jun 10, 2026
13:18
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling
Saadia Bashir Hassan1, Hala Gali-Muhtasib, Hanna Göransson
1Division of Clinical Pharmacology, Department of Medical Sciences, University Hospital, 751 85 Uppsala, Sweden. sadia.hassan@medsci.uu.se
Anticancer Research
|July 24, 2010
Summary
Alpha terpineol, found in Salvia libanotica, inhibits tumor cell growth by blocking the NF-kappaB pathway. This natural compound shows promise as an anti-cancer agent, particularly against small cell lung carcinoma.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Alpha terpineol is a bioactive compound derived from Salvia libanotica essential oil.
- This compound has demonstrated potential anti-tumorigenic properties.
Purpose of the Study:
- To evaluate the anti-cancer effects of alpha terpineol.
- To elucidate the molecular mechanisms underlying its anti-tumor activity.
Main Methods:
- In vitro cytotoxicity assays on various tumor cell lines.
- Mechanistic studies using cell line panels and gene expression analysis (Connectivity Map).
- NF-kappaB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) pathway assays to assess inhibition of translocation and activity.
Main Results:
- Small cell lung carcinoma cell lines were most sensitive to alpha terpineol.
- Alpha terpineol was identified as an inhibitor of the NF-kappaB pathway.
- Dose-dependent inhibition of NF-kappaB activity and down-regulation of NF-kappaB-related genes (e.g., IL-1 beta, IL1R1) were observed.
Conclusions:
- Alpha terpineol exhibits anti-tumor activity.
- The mechanism involves the inhibition of the NF-kappaB signaling pathway.
- Alpha terpineol represents a potential therapeutic agent for cancer treatment.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...